Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
EGHA
STRONG SELLREMOVEEGH Acquisition Corp. · Financial Services · United States · $212M · Avg Vol: $522K/d
EGH Acquisition Corp is a blank check company. It has no operating business, no revenues, and no competitive advantage, making it entirely unsuitable for a concentrated quality-growth portfolio.
COMPANY DESCRIPTION
EGH Acquisition Corp. is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. With no operating assets or ongoing business activities, the company is actively seeking a suitable target for its initial business combination. Its success hinges on the management team's ability to identify and merge with a compelling private enterprise.
FINANCIAL SUMMARY (USD)
| Year | 2025 |
|---|---|
| Revenue | 0 |
| EPS | 0.22 |
| Shares | 21M |
| Debt | 6M |
| Equity | 149M |
| Op CF | -719,445 |
| Inv CF | -150M |
| Fin CF | 151M |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of EGHA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| EGHA | EGH Acquisition Corp.(you) | $212M | 16 | STRONG SELL |
| FIGX | FIGX Capital Acquisition Corp. | $198M | 17 | STRONG SELL |
| GSHR | Gesher Acquisition Corp. II | $213M | 19 | STRONG SELL |
| DAAQ | Digital Asset Acquisition Corp. | $237M | 15 | STRONG SELL |
| TDAC | Translational Development Acquisition Corp. | $236M | 14 | STRONG SELL |
| MACI | Melar Acquisition Corp. I | $234M | 13 | STRONG SELL |
| DMAA | Drugs Made In America Acquisition Corp. | $257M | 15 | STRONG SELL |
| RAAQ | Real Asset Acquisition Corp. | $262M | 15 | STRONG SELL |
| PLMK | Plum Acquisition Corp. IV | $258M | 14 | STRONG SELL |
| VNME | Vendome Acquisition Corporation I | $255M | 13 | STRONG SELL |
Peer medians: ROE 10.8% · P/E 13.6x · Gross margin 0.0%